| Quarterly Financials | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 9 | 12 | 10 | 15 | 13 | 23 |
| Expenses | 5 | 7 | 7 | 7 | 8 | 16 |
| EBITDA | 5 | 5 | 3 | 9 | 5 | 7 |
| Operating Profit % | 52 % | 39 % | 27 % | 57 % | 40 % | 30 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit Before Tax | 4 | 4 | 2 | 8 | 4 | 5 |
| Tax | 1 | 1 | 0 | 2 | 1 | 1 |
| Net Profit | 3 | 3 | 1 | 5 | 3 | 4 |
| EPS in ₹ | 0.65 | 0.52 | 0.22 | 0.85 | 0.47 | 0.52 |
Gujarat Kidney and Super Speciality
Gujarat Kidney and Super Speciality
141.25
-2.02
(-1.41%)
Market Cap
1,113.66 Cr
PE Ratio
84.59
Volume
11,50,764.00
Day High - Low
148.34 - 139.52
52W High-Low
147.80 - 98.36
Key Fundamentals
Market Cap
1,113.66 Cr
EPS
1.85
PE Ratio
84.59
PB Ratio
3.96
Book Value
36.06
EBITDA
16.70
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
35.02
Debt to Equity
0.39
Actual
Company News
View All News
Board Meeting on May 28
2 days ago
2 days agoGujarat Kidney And Superspeciality Limited will hold a board meeting on May 28, 2026, to consider Q4 and FY26 audited results.
GKSL to Deploy 100 AI-Powered Dialysis MachinesMay 14, 2026
May 14, 2026Gujarat Kidney and Super Speciality announces procurement of 100 AI-enabled haemodialysis machines, with Phase 1 deployment of 8 units at Godhra facility within 10 days.
Gujarat Kidney and Super Speciality Limited shareholders approved three key resolutions through postal ballot on 25-04-2026, including healthcare expansion funding and financial statement revision.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,404.00 | #1 1,20,836.63 | 60.02 | #1 25,228.50 | 14.70 | #1 2,032 | 33.00 | 73.21 | |
1,000.85 | 97,396.22 | 69.05 | 8,373.45 | 16.56 | 1,464 | 7.27 | 44.00 | |
970.35 | 73,257.36 | 73.94 | 9,127.84 | 16.28 | 1,064 | 44.26 | 61.20 | |
1,940.00 | 39,646.00 | 48.63 | 7,896.04 | #1 41.63 | 788 | 13.53 | 62.30 | |
746.90 | 38,698.46 | 91.78 | 4,643.22 | 8.32 | 384 | #1 79.65 | 58.59 | |
1,249.30 | 33,579.98 | 60.09 | 4,410.27 | 16.94 | 584 | 39.64 | 67.84 | |
756.80 | 30,282.51 | 126.29 | 3,904.60 | 27.31 | 198 | -68.80 | 59.04 | |
479.70 | 15,197.26 | 90.43 | 2,080.08 | 18.39 | 168 | 17.65 | 65.24 | |
1,350.00 | 13,710.49 | 52.98 | 1,566.90 | 17.46 | 244 | 38.41 | 65.06 | |
279.09 | 12,054.76 | #1 40.99 | 1,679.36 | 17.77 | 272 | 46.56 | 75.36 |
Growth Rate
Revenue Growth
634.55 %
Net Income Growth
458.82 %
Cash Flow Change
1,024.79 %
ROE
120.81 %
ROCE
177.89 %
EBITDA Margin (Avg.)
-14.69 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 4 | 4 | 21 | 55 |
| Fixed Assets | 3 | 0 | 14 | 31 |
| Current Assets | 1 | 1 | 7 | 22 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 1 | 4 | 7 | 24 |
| Total Equity & Liabilities | 4 | 4 | 21 | 55 |
| Current Liabilities | 4 | 4 | 4 | 22 |
| Non Current Liabilities | 0 | 0 | 6 | 7 |
| Total Equity | 0 | 0 | 11 | 27 |
| Reserve & Surplus | 0 | 0 | 2 | 15 |
| Share Capital | 0 | 0 | 0 | 11 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 1 | 2 |
| Investing Activities | 0 | 0 | -18 |
| Operating Activities | 0 | 1 | 14 |
| Financing Activities | 0 | -1 | 6 |
Share Holding
| % Holding | Mar 2025 | Dec 2025 | Mar 2026 |
| Promoter | 99.10 % | 71.45 % | 71.45 % |
| FIIs | 0.00 % | 10.47 % | 4.88 % |
| DIIs | 0.00 % | 1.67 % | 0.56 % |
| Government | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 11.57 % | 10.64 % |
| Others | 0.90 % | 4.84 % | 12.46 % |
| No of Share Holders | 7 | 7 | 18,301 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Feb 2026 |  Quarterly Result Announcement | NA | 14 Feb 2026 | 108.65 | 110.40 |
Announcements
Board Meeting Intimation for Consideration And Approval Of Audited Quarterly And Yearly Financial Results And Other Matters.
2 days ago
2 days agoFormat of the Annual Disclosure to be made by an entity identified as a LC - Annexure B210 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Monitoring Agency Report10 days ago
10 days agoGKSL Scales Up Renal Care: 100 Units AI-Powered Haemodialysis Machines To Be Inducted Across Network. First 8 Machines To Go Live At Gujarat Multi Speciality Hospital Godhra Gujarat Within 10 Days Following Completion Of All Required InspectionsMay 14, 2026
May 14, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-AcquisitionApr 27, 2026
Apr 27, 2026Appointment of Company Secretary and Compliance OfficerApr 27, 2026
Apr 27, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 25, 2026
Apr 25, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 25, 2026
Apr 25, 2026Intimation About Payment Of Fine Levied Under Regulation 29 Of SEBI (LODR) Regulations 2015Apr 20, 2026
Apr 20, 2026Intimation Of Receipt Of Notice For Non Compliance With Regulation 29(2)/29(3) Of SEBI (LODR) Regulations 2015Apr 16, 2026
Apr 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 26, 2026
Mar 26, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 25, 2026
Mar 25, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Wholly Own Subsidiary.Mar 23, 2026
Mar 23, 2026Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015-Update.Mar 21, 2026
Mar 21, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 19, 2026
Mar 19, 2026Board Meeting Outcome for Outcome For Board Meeting Outcome For Board Meeting Hold On 19Th March 2026.Mar 19, 2026
Mar 19, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Intimation For Receipt Of Notice For Non-Compliance With Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20Mar 18, 2026
Mar 18, 2026Results-Delay in Financial ResultsMar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 03, 2026
Mar 03, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 15, 2026
Feb 15, 2026Statement Of Deviation And Variation For Quarter Ended 31 Decembre 2025Feb 15, 2026
Feb 15, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 14, 2026
Feb 14, 2026Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 14, 2026
Feb 14, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On February 14 2026 For The Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025 And Other Businesses MFeb 14, 2026
Feb 14, 2026Board Meeting Intimation for Postponement And Rescheduling Of Board MeetingFeb 11, 2026
Feb 11, 2026Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 10, 2026
Feb 10, 2026Board Meeting Outcome for Board Meeting Outcome For Board Meeting Hold On 5Th February 2026.Feb 05, 2026
Feb 05, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2026
Jan 10, 2026Board Meeting Outcome for Outcome Of Board Meeting Hold On 6Th January 2026.Jan 06, 2026
Jan 06, 2026Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 2Nd January 2026Jan 02, 2026
Jan 02, 2026Closure of Trading WindowDec 30, 2025
Dec 30, 2025Listing of Equity Shares of Gujarat Kidney and Super Speciality LtdDec 30, 2025
Dec 30, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.01% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 70.18
ATR(14)
Less Volatile 6.21
STOCH(9,6)
Neutral 63.77
STOCH RSI(14)
Oversold 13.17
MACD(12,26)
Bullish 0.12
ADX(14)
Strong Trend 46.22
UO(9)
Bearish 50.52
ROC(12)
Uptrend And Accelerating 15.83
WillR(14)
Overbought -16.30
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
